Skip to main content

Carl Gordon

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Carl Gordon

The company reported in an 8-K filed February 20, 2025 that Carl Gordon resigned as Board of Directors, effective February 20, 2025.

“On February 20, 2025, Carl Gordon notified Terns Pharmaceuticals, Inc. (the "Company") of his resignation from the Company's Board of Directors (the "Board"), effective as of February 20, 2025.”
Company Form 8-K, filed February 20, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Organization not stated

    Board Member

    Proxy statement

    2018-01-01–2025-02-20

  • Organization not stated

    Board Member

    Proxy statement

    2018-01-01–2025-02-20

Company network

Recorded roles and call appearances connecting this person to public companies.

Company

Board Member

2018-01-01–2025-02-20

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.